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Summary Monoclonal antibodies (McAbs) directed against the framework determinants of Class I and Class
II products of the major histocompatibility complex (MHC) and against leucocyte differentiation antigens
were used in an indirect immunoperoxidase technique to study their expression in normal, benign
(adenomatous polyps) and malignant disease of the colon. Class I products (detected by the McAb 2AI) were
strongly expressed on all cell types in normal and benign tissues but some carcinomas exhibited a
heterogenous pattern of epithelial cell staining and 4/15 were completely negative. Class II products (detected
by TDR31.1) were strongly expressed on cells (mainly B lymphocytes) within the lamina propria. In
carcinomas TDR31.1 staining was mainly interstitial, but in 2/15, DR+ epithelial cells were also detected. In
normal and benign tissues, leucocytes (reactive with 2D1) found predominantly in the lamina propria,
comprised T cells mainly of the helper/inducer (OKT4) subset, DR+ cells in approx. equivalent proportion
and a few OKM1+ cells mostly of macrophage morphology. Occasional intraepithelial lymphocytes were of
cytotoxic/suppressor (OKT8) phenotype. In malignant neoplasms, there was wide inter and intra-tumour
variation in the proportion of leucocytes which were heterogeneous with respect to cell type and confined
mainly to the stroma. T cells were consistently predominant, but B cells and macrophages were also present.
Two neoplasms showed unequivocal evidence of a shift (relative to peripheral blood) in favour of the OKT8+
subset, but in the majority of tumours OKT4+; and OKT8+ cells were present in roughly similar proportions.
Natural killer cells (monitored with Leu7, HNK1) were virtually undetectable in both normal and malignant
tissues. There were no apparent correlations between the extent and type of leucocyte infiltration, tumour
differentiation or expression of MHC products. Some implications for the extrapolation of in vitro data on
leucocyte function to the in vivo situation are discussed.
There is increasing awareness that the biological
behaviour of tumour cells, which varies widely
between neoplasms of the same histological type
and grade, is dictated to a large extent by
interaction with neighbouring cells and their
environment in general.
The correlation between the presence of intra
tumour inflammatory cells and prognosis which
appears to exist for some neoplasms, suggests that
infiltrative leucocytes may constitute a potentially
important component of the interface between
tumours and the normal cells of the host.
(Underwood, 1974; loachim, 1976; see also Haskill,
1982; Moore, 1984). Whether the defensive role
frequently attributed to inflammatory cells is a
consequence of direct effector functions (as
suggested by in vitro studies), or a secondary
phenomenon unrelated to the capacity of the
tumour to evoke an immune response, is not
altogether clear.
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Extensive in vitro studies suggest that for some
tumours there is a correlation between systemic
anti-tumour immunity and prognosis (Vanky et al.,
1983a,b). Limited functional data are also available
for leucocytes recovered from the tumour site, but
the coexistence of populations with cytotoxic
activity (Totterman et al., 1978, Werkmeister et al.,
1979; Vose et al., 1981) as well as suppressive
activity (Vose & Moore, 1979), has rendered the
interpretation of in situ events difficult.
With the advent of monoclonal antibodies to
leucocyte populations and their subsets it is possible
to examine the heterogeneity of the inflammatory
response to neoplasia under conditions where the
microanatomical relationships between potential
effector cells and the neoplastic population, crucial
to the extrapolation of in vitro data to in vivo
events, are maintained (Rowe & Beverley, 1984;
Whitwell et al., 1984; Bhan & Des Marais, 1983;
Watanabe et al., 1983, Ruiter et al., 1982). The
approach also has the advantage that properties of
the plasma membranes of tumour cells (e.g.
expression of MHC products) critical for certain
types of immune interaction, may be simultaneously
examined (Fleming et al., 1981; Daar et al., 1982;
Daar & Fabre, 1983).
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We present herein a preliminary study of human
colon carcinoma, against which systemic and in situ
immune reactivity have been demonstrated and for
which a positive correlation exists between
lymphoid infiltration and prognosis (Murray et al.,
1975; Spratt & Spjut, 1967; Watt & House, 1978;
Svennevig et al., 1984). For this purpose we have
compared the expression of histocompatibility and
leucocyte differentiation antigens in normal colon
and in benign (adenomatous polyps) and malignant
tumours.
Patients and methods
The patients were all admitted for resection of large
bowel tumours diagnosed prior to operation
radiologically or by biopsy. Histological
confirmation and staging were done on paraffin
sections. Normal large bowel away from the
tumour was examined in eight of the fifteen cases.
Three of the cases had associated small tubulo-
villous adenomata which were also included.
The age range of patients (9 males; 6 females)
was 59-83 years. The sites of the primary
tumour are listed in Table II together with Dukes'
staging (Dukes & Bussey, 1958). One patient (No.
13) had been taking Salozopyrin for 3 months at
the time of operation for recurrent diarrhoea;
otherwise none of the patients was taking
significant medication.
Tissue specimens
Firm tissue from the tumour mass removed at
laparotomy was wrapped in tin foil, snap frozen in
liquid nitrogen and stored at -70° or over liquid
nitrogen. Serial sections 5-10jim thick (depending
on the properties of the tissue) were cut, dried at
37°C for 30min and stored at -20°C under
dessicated conditions prior to staining within 7
days. Prolonged storage was avoided.
Immunohistochemical staining
The procedures used in this study have been
described in detail previously (Whitwell et al.,
1984). Briefly, acetone-fixed sections were incubated
in the (appropriately diluted) monoclonal antibody
(McAb) first layer, washed and then incubated in
diluted horse radish peroxidase-conjugated rabbit
anti-mouse IgG containing normal human serum.
The peroxidase reaction was subsequently
developed in diaminobenzidine containing freshly
added hydrogen peroxide and the sections washed,
counterstained in Gills No. 2 Haemalum and
mounted. Immersion in buffered osmium tetroxide
was required for some McAbs. The specificity of
the McAbs was routinely checked on sections of
palatine tonsils, but no attempt was made to
abolish endogenous staining, which was readily
distinguishable from specific immunostaining.
Monoclonal antibodies (McAbs)
Details of the McAbs used in this study have been
given previously (Whitwell et al., 1984) and are
summarized in Table I.
Results
Control (McAb non-treated) sections revealed a
small population of cells confined to the lamina
propria in normal colon and occasionally scattered
in the stroma of tumours, which were invariably
distinguishable from cells exhibiting specific staining
with the various McAbs. Histopathological and
immunostaining data on serial sections from the
malignant tumours are summarized in Table II, and
illustrative examples of immunostaining in Figures
1-7.
Normal colon
MHC Class I products (reactive with 2A1) were
strongly expressed on all cell types in normal colon,
with the exception of the submucosa where staining
was most clearly associated with lining cells of the
submucosal blood vessels (Figure 1).
MHC Class II products (reactive with TDR31.1)
were strongly expressed in the lamina propria; the
most intense staining consisting of densely packed
leucocytes polarized towards the lumen. All
epithelial cells were negative.
Leucocytes (reactive with 2D1) were found
mainly in the mucosa, with a few cells scattered
within the submucosa, and predominantly in the
lamina propria. Occasional intraepithelial leucocytes
were detectable. T lymphocytes (reactive with
UCHT1) were found mainly in the lamina propria
where they were randomly distributed in some areas
and present as aggregates in others. T cells
accounted for approx. one third of lamina propria
leucocytes, but intraepithelial T cells were identified
only occasionally. The helper-inducer subset
(OKT4+) exceeded the cytotoxic/suppressor subset
(OKT8+) in the lamina propria, the ratio being of
the order of 3:2. The few T cells identified in the
luminal and glandular epithelium appeared to be
predominantly of OKT8 phenotype.
B cells (detected with MAS 020) were detected
predominantly in juxtaposition to the luminal
epithelium. In this respect, the staining pattern
resembled, but was not identical with that of the
anti-MHC Class II McAb (TDR31.1). TheMHC AND LEUCOCYTE ANTIGENS IN COLONIC DISEASE 701
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Figure 1 Anti MHC Class I (2A1) staining of normal Figure 2 Uniform anti MHC Class I (2A1) staining
colon showing strong reactivity with glandular and of a well-differentiated adenocarcinoma. (Obj. x 10).
luminal epithelia, leucocytes of the lamina propria and
the lining cells of submucosal blood vessels.
(Obj. x 10).
Figure 3 Negative anti MHC Class I (2A1) staining
of an area of a moderately well-differentiated adeno-
carcinoma with positive intervening fibroblastic tissue
and leucocytes. Tumour cells of other areas of this
neoplasm were 2A1+. (Obj. x 10).
Figure 4 Anti MHC Class II (TDR31.1) staining of
carcinoma cells adjacent to an area of DR- cells.
(Obj. x 25).
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Figure 5 Anti T helper/inducer subset (OKT4) Figure 6 Anti T cytotoxic/suppressor subset (OKT8)
staining cells diffusely distributed within a moderate- staining cells diffusely distributed in an adjacent field
poorly differentiated adenocarcinoma. Osmium- to Figure 5. (Obj. x25).
tetroxide treated. (Obj. x 25).
Figure 7 Anti macrophage/large granular lymphocyte
(OKMI) staining of cells within a moderate-poorly
diffrerentiated adenocarcinoma. (Obj. x 25).
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distribution of B and T cells was thus micro-
anatomically distinct. Virtually no intraepithelial
leucocytes were reactive with this McAb.
The few positive OKM1+ cells within the lamina
propria and scattered about connective tissue
appeared to be mainly of macrophage morphology.
Leu 7+(HNKI)+ cells were detected very
occasionally.
Benign (adenomatous polyps) tissue
The staining patterns of the three small tubulo-
villous adenomata scarcely differed from those of
the normal tissues for any of the McAbs tested,
with the exception of one specimen in which the
glandular epithelium exhibited patchy positivity
with the anti-MHC Class II reagent (TDR31.1).
Colorectal carcinoma
By contrast with the consistent visualisation of
leucocytes and stromal elements, expression of
MHC Class I products (reactive with 2A1) was
variable and unpredictable. Eight of nine moderate-
to-well differentiated carcinomas were positive
(Figure 2), while in the remaining moderate-to-
poorly differentiated tumours the pattern of
staining was either heterogenous (Figure 3) or
negative and apparently unrelated to intra-tumour
variability in the degree of differentiation.
Cells expressing MHC Class II products (reactive
with TDR31.1) were predominantly leucocytes
present in the interstitial stroma. Comparison of
staining with the pan T cell and B cell McAbs
(UCHT1 and MAS 020) suggested that a
proportion of these may have been activated T cells
[The anti Tac McAb (Uchiyama et al., 1981) was
not available for this study.] By contrast with
normal tissue, 2/15 specimens exhibited patchy
staining of epithelial cells, (Figure 4) which was
unrelated to tumour differentiation.
The common leucocyte McAb (2D1) was
particularly useful for gross estimation of the
leucocyte component of all tumours. Leucocytes
were found predominantly in the stroma or
diffusely scattered throughout the tumour mass.
The extent of infiltration, which showed wide inter-
and intra-tumour variation, was not related to
necrosis.
T cells (monitored with UCHT1) exceeded B cells
(reactive with MAS 020) in the reactive stroma and
in the tumour mass and comprised helper/inducer
(OKT4+) and cytotoxic/suppressor (OKT8+)
subsets in approximately similar proportions
(Figures 5 and 6). In two notable cases (Table II,
patients 2 and 8), there was a distinct shift in
favour of the T8 phenotype.
OKMI + cells (anti-monocyte/NK McAb) were
present mainly in stromal cords (Figure 7) and
occasionally within the tumour mass. There was no
correlation between OKMI+ and Leu 7+ (HNKl+)
cells (of which - 60% in peripheral blood also
express the OKM1 marker-Abo et al., 1982a),
suggesting that the majority of OKM1' cells in the
stroma were macrophages, as distinct from large
granular lymphocytes (Ortaldo et al., 1981). Leu 7+
(HNKI+) cells were in fact negligible in the seven
tumours examined with this reagent.
Discussion
These data confirm that in common with most
normal epithelia, there is strong expression of
MHC Class I products, but not of Class II
products, on normal colorectal epithelium (Daar &
Fabre, 1983). Similarly, in common with other
normal tissues, the distribution of various
leucocytes and their subsets within the colorectal
mucosa is spatially ordered and predictable (Selby
et al., 1981). Leucocytes are principally represented
in the lamina propria, where the major T cell subset
is of helper/inducer phenotype. Its primary role in
association with macrophages and other antigen-
presenting cells may be to provide local B cell help.
The association of cytotoxic/suppressor
lymphocytes with HLA Class I-positive, Class II-
negative epithelium on the other hand, suggests that
their role in the local immune response is
interaction with epithelial cells altered by viral
infection or other foreign (non-self) antigens (Selby
et al., 1981). HNK1+ cells, attributed with NK/K
cell activity were not significantly represented in
either the epithelium or lamina propria.
With the possible exception of DR' cells in the
glandular epithelium of one adenoma, the pattern
and intensity of staining of these lesions with the
panel of McAbs scarcely differed from that of
normal colon. By contrast, the expression of MHC
products and the extent and type of leucocyte
infiltration in malignant tumours was far less
predictable. The most conspicuous differences were
in respect of loss of Class I antigen expression and
gain of Class II products. Four of 15
adenocarcinomas failed to express Class I antigens
at all, in 2/15 expression was heterogenous, while
2/15 expressed Class II products. The data indicate
that loss of MHC Class I products at least, is not
unusual, being encountered in breast carcinoma
(Fleming et al., 1981; Bhan & Des Marais, 1983;
Rowe & Beverley, 1984); gynaecological neoplasms
(Ferguson & Moore, unpublished data) and
colorectal cancer (Daar & Fabre 1983) alike. In this
pilot series, there was no apparent correlation
between the expression of either class of MHC
product and the degree of differentiation or the
extent and type of leucocyte infiltration.MHC AND LEUCOCYTE ANTIGENS IN COLONIC DISEASE 707
The loss of Class I antigen expression has
implications for the associative recognition of
putatively antigenic tumour cells by cytotoxic T
lymphocytes (McMichael, 1978). The Class I-
negative populations could conceivably have arisen
through immunoselection of Class I-positive clones
expressing tumour-associated antigens. On this
hypothesis, given the evidence for lymphocyte
recognition of colorectal cancer cells, (Werkmeister
et al., 1979; Vose et al., 1981) it is perhaps
surprising that the Class I-positive tumours do not
show overtly greater leucocyte infiltration with
evidence of local cytodestruction. The fact that
cytotoxicity mediated by CTL and NK cells can be
demonstrated against isolated tumour targets does
not necessarily mean that these effectors are
functional or even represented at the tumour site.
Evidently, T cells are only occasionally in contact
with tumour cells. Furthermore, cells of NK
phenotype are noticeably absent not only from
colonic tumours but also from other types (Bhan &
Des Marais, 1983; Pizzolo et al., 1984; Watanabe et
al., 1983; Whitwell et al., 1984). Even allowing for
the fact that not all peripheral blood NK activity is
represented in the Leu 7+ (HNK1 +) population,
(Abo et al., 1982b) recent (unpublished)
immunohistological experience with the B73.1
monoclonal antibody (Perussia et al., 1983 a,b) and
extensive functional data (Moore & Vose, 1981;
Vose et al., 1981; Eremin et al., 1981; Introna et al.,
1983) are consistent with a paucity of NK cells at
the tumour site.
The relatively infrequent expression of DR
antigen on carcinoma cells in this series may be a
consequence of patient selection since poorly
differentiated tumours which are associated with a
more uniform expression of HLA-DR (Rognam et
al., 1983) were a minority. The extent of any
similarity with the expression of these determinants
on human bronchial, intestinal and mammary
epithelia (Natali et al., 1981) - where extrinsic
factors such as hormonal changes associated with
pregnancy and lactation (Klareskog et al., 1980)
and the development of graft versus host disease
(Lampert et al., 1981; Mason et al., 1981) are
influential - is presently unknown. DR antigen
could conceivably augment tumour-associated T
cell immune responses (Thompson et al., 1982;
Guerry et al., 1984) and there is currently much
interest in the observation that cytotoxic cells of T4
phenotype are restricted by Class II determinants
(Reinherz et al., 1983).
Analysis of leucocyte infiltrates indicated that
these were predominantly to be found in the
interstitial connective tissue. Our observation that
cells of T8 phenotype either exceeded or were
present in approximately equal numbers to those of
T4 phenotype is suggestive of some tissue selection
in favour of the cytotoxic/suppressor subset.
However, the factors which determine this ingress,
including the extent to which tumour
immunogenicity plays a role in the process, are
unknown. On immunohistological evidence alone,
predominance of the T8 subset might imply a
preponderance of either cytotoxic or suppressor T
cells at the tumour site. A positive relationship
between leucocyte infiltration and survival in a
subgroup of Dukes B patients has been asserted
(Svennevig et al., 1984) and some in vitro functional
data are also consistent with a defensive anti-
tumour role for inflammatory cells (Werkmeister et
al., 1979; Vose et al., 1981). However, intra-tumour
leucocytes also comprise suppressor T cells (Vose &
Moore, 1979). Clearly, the in situ host response is
complex and must await further clarification. The
availability of McAbs to a broader spectrum of
differentiation and function-associated determinants
may assist in this direction.
This study was supported by grants from the Cancer
Research Campaign of Great Britain. The authors
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